{
    "nct_id": "NCT06173310",
    "official_title": "DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer",
    "inclusion_criteria": "* Adult patients (age 19 years or older).\n* Patients with newly diagnosed and untreated borderline resectable pancreatic cancer.\n* Patients with signed informed consent.\nHealthy volunteers allowed\nMust have minimum age of 19 Years",
    "exclusion_criteria": "* Any history of prior radiation or chemotherapy or surgical removal for pancreatic cancer.\n* Participants with safety contraindications to MRI examination (determined by standard clinical screening).\n* Participants who are pregnant, lactating or are planning to become pregnant during the study.\n* Participants who are planning to father a child during the study.",
    "miscellaneous_criteria": ""
}